Abstract:Background Hepatic stellate cells (HSCs) are the key drivers of fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD), the fastest growing cause of hepatocellular carcinoma worldwide. HSCs are heterogenous, and a senescent subset of HSCs is implicated in hepatic fibrosis and HCC. Administration of anti-uPAR (urokinase-type plasminogen activator receptor) CAR T cells depletes senescent HSCs and attenuates fibrosis in murine liver injury models, including MASLD. However, the comprehensive features of senescent HSCs in MASLD, as well as their cellular ontogeny have not been characterized. Aims and Methods Our aims were to comprehensively characterize and define the origin of senescent HSCs in human and murine MASLD by integrating senescence-associated beta galactosidase activity with immunostaining, flow cytometry and single nuclear RNA-sequencing (snRNAseq). We integrated the immunohistochemical profile with a senescence score applied to snRNAseq data to characterize senescent HSCs, and mapped the evolution of uPAR expression in MASLD. Results Using pseudotime trajectory analysis, we establish that senescent HSCs arise from activated HSCs. While uPAR is expressed in MASLD, the magnitude and cell-specificity of its expression evolve with disease stage, such that in early disease, uPAR is more specific to activated and senescent HSCs, and in late disease, uPAR is also expressed by myeloid-lineage cells including Trem2 + macrophages and myeloid-derived suppressor cells. Furthermore, we identify novel surface proteins expressed on senescent HSCs in human and murine MASLD that could be exploited as therapeutic targets. Conclusions These data define features of HSC senescence in human and murine MASLD, establishing an important blueprint to target these cells as part of future antifibrotic therapy. LAY SUMMARY Hepatic stellate cells (HSCs) are the primary drivers of scarring in chronic diseases of the liver. As injury develops, a subset of HSCs become senescent; these cells are non-proliferative and pro-inflammatory, thereby contributing to worsening liver injury. Here we show that senescent HSCs are expanded in metabolic dysfunction-associated steatotic liver disease (MASLD) in humans and mice, and we trace their cellular origin from the activated HSC subset. We further characterize expression of uPAR (urokinase plasminogen activated receptor), a protein that marks senescent HSCs, and report that uPAR is also expressed by activated HSCs in early injury, and immune cells as liver injury advances. We have integrated high resolution single nuclei sequencing with immunostaining and flow cytometry to identify five other novel proteins expressed by senescent HSCs, including mannose receptor CD206, which will facilitate future efforts to clear senescent HSCs to treat fibrosis.

Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies

Modelling the spatiotemporal dynamics of senescent cells in wound healing, chronic wounds, and fibrosis

Single-cell morphology encodes functional subtypes of senescence in aging human dermal fibroblasts

Abstract 100: Omics Strategies To Identify Senescent Cells Mediating Extracellular Matrix Remodeling During Vascular Disease

Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence

Systematic transcriptomic analysis and temporal modelling of the senescent human fibroblast

Ex Vivotissue Perturbations Coupled to Single Cell RNA-seq Reveal Multi-Lineage Cell Circuit Dynamics in Human Lung Fibrogenesis

Integration of transcriptomes of senescent cell models with multi-tissue patient samples reveals reduced COL6A3 as an inducer of senescence

Dissecting Murine Muscle Stem Cell Aging through Regeneration Using Integrative Genomic Analysis

Modulation of fracture healing by the transient accumulation of senescent cells

Characterization of cellular senescence in aging skeletal muscle

Single Cell Transcriptomics Reveals Global Markers of Transcriptional Diversity Across Different Forms of Cellular Senescence

Developing transcriptomic signatures as a biomarker of cellular senescence

Identifying specific functional roles for senescence across cell types

SenePy: Unveiling the Cell-Type Specific Landscape of Cellular Senescence through Single-Cell Analysis in Living Organisms

Cellular Senescence: Mechanisms, Morphology, and Mouse Models

Author Correction: Senescence Atlas Reveals an Aged-Like Inflamed Niche That Blunts Muscle Regeneration

Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population

SenNet recommendations for detecting senescent cells in different tissues

Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatotic liver disease

Senescent cell transplantation into the skin induces age-related peripheral dysfunction and cognitive decline